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Background: Artificial neural networks (ANNs) have been used to classify eye diseases, such as diabetic retinopathy (DR)
and glaucoma. DR is the leading cause of blindness in working-age adults in the developed world. The implementation
of DR diagnostic routines could be feasibly improved by the integration of structural and optical property test
measurements of the retinal structure that provide important and complementary information for reaching a
diagnosis. In this study, we evaluate the capability of several structural and optical features (thickness, total reflectance
and fractal dimension) of various intraretinal layers extracted from optical coherence tomography images to train a
Bayesian ANN to discriminate between healthy and diabetic eyes with and with no mild retinopathy.
Results: When exploring the probability as to whether the subject’s eye was healthy (diagnostic condition, Test 1), we
found that the structural and optical property features of the outer plexiform layer (OPL) and the complex formed by
the ganglion cell and inner plexiform layers (GCL + IPL) provided the highest probability (positive predictive value (PPV)
of 91% and 89%, respectively) for the proportion of patients with positive test results (healthy condition) who were
correctly diagnosed (Test 1). The true negative, TP and PPV values remained stable despite the different sizes of training
data sets (Test 2). The sensitivity, specificity and PPV were greater or close to 0.70 for the retinal nerve fiber layer’s
features, photoreceptor outer segments and retinal pigment epithelium when 23 diabetic eyes with mild retinopathy
were mixed with 38 diabetic eyes with no retinopathy (Test 3).
Conclusions: A Bayesian ANN trained on structural and optical features from optical coherence tomography data can
successfully discriminate between healthy and diabetic eyes with and with no retinopathy. The fractal dimension of the
OPL and the GCL + IPL complex predicted by the Bayesian radial basis function network provides better diagnostic
utility to classify diabetic eyes with mild retinopathy. Moreover, the thickness and fractal dimension parameters of the
retinal nerve fiber layer, photoreceptor outer segments and retinal pigment epithelium show promise for the
diagnostic classification between diabetic eyes with and with no mild retinopathy.Background
Artificial neural networks (ANNs) have been widely used
in both modern industries and scientific research to
perform diverse and sophisticated tasks, such as data
processing, pattern recognition, system controls and
medical diagnosis [1-4]. In the field of medical diagnosis,
ANNs have been widely applied in different areas of
medical diagnosis, including cardiology, oncology, radi-
ology and ophthalmology [5-8]. Because of the pre-
diction capability of ANNs, they can be used to diagnose* Correspondence: dcabrera2@med.miami.edu
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reproduction in any medium, provided the ordiseased subjects in clinical practice. The basic idea is to
compare the measured target features with the predicted
target features using a trained ANN that was specifically
designed for a particular type of patient group. The results
from comparisons using one criterion could determine
whether the questionable subjects have a disease or not.
With multiple criteria, ANNs could classify the question-
able subjects according to differences in disease type or
disease stage. In general, criteria are defined as statistically
determined values or ranges that represent typical disease
characteristics. The prediction and classification performed
by ANNs could save doctors and patients time by deter-
mining the diagnosis of the questionable subjects in ad-
vance of treatments. The use of ANNs could improveLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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nostic time and medical costs as well as to increase the
quality and accessibility of preventive care for individuals
with diabetes. However, it should be noted that the costs of
medical devices used in the implementation of ANNs
should be taken into account as a potential limiting factor
to their accessibility.
In ophthalmology, the detection of functional vision
abnormalities plays a fundamental role in the diagnosis
of eye diseases. Such a task depends not only on the use
of a variety of precise optical instruments but also on
technicians who are well trained in accurate ophthalmic
techniques. The use of multiple instruments and techni-
cians could decrease measurement precision, whereas the
implementation of ANNs could improve it, in addition to
reducing waiting times and medical costs. Currently, most
ANN mapping of the eye structure and function involves
training with measurements of retinal structure and visual
function. For example, Zhu et al. developed an ANN using
a Bayesian radial basis function to map the structure-
function relationship between the retinal nerve fiber layer
and visual function in glaucoma. The results demonstrated
that ANNs using a Bayesian radial basis function could ef-
fectively improve the agreement between predicted visual
function and measured visual function compared with re-
sults obtained using linear regression [9]. Furthermore,
Zhu et al. quantitatively evaluated the discordance between
the visual function predicted by a trained ANN and the
measured visual function in glaucoma. Specifically, 39% of
the predicted visual function showed significant discord-
ance with the measured visual function [10].
Aside from the prediction of visual function, these
ANNs have also been used to classify eye diseases, such
as diabetic retinopathy. Diabetic retinopathy (DR) is a
severe and widely spread eye disease increasing in inci-
dence as the worldwide number of patients with diabetes
grows [11]. Retinopathy is not common during the first
5 years’ duration of type 1 diabetes and at least some
form of DR is present after 20 years of the onset of type
2 diabetes [12]. Thus, an objective test for the early diagno-
sis and evaluation of treatment in DR is certainly needed in
order to identify the individuals at high risk for vision-
threatening problems. The role of Optical Coherence
Tomography (OCT) in the assessment and management
of the diabetic retina has become significant in under-
standing the vitreoretinal relationships and the internal
architecture of the retinal structure [13].
Previous work of ANN applications in DR has demon-
strated that the input feature is no longer restricted to
the thickness of the retina; it can be expanded to differ-
ent types of features such as the diameter of blood ves-
sels, the radius of the corneal surface curvature and the
cross-sectional area of blood vessels [14-16]. For ex-
ample, Yun et al. classified the different stages of diabeticretinopathy (i.e., moderate, severe and proliferative DR)
and differentiated them from the healthy retina using a
three-layer backpropagation (BPA) ANN. In their method,
the perimeter and area of the veins, hemorrhages and
microaneurysms were extracted from retinal fundus im-
ages and used as input to the classifier. The ANN was
trained with 74 subjects (20 healthy, 27 moderate, 13 se-
vere and 27 proliferative) and was tested with 37 subjects
(9 healthy, 11 moderate, 5 severe and 12 proliferative).
Their system achieved a sensitivity of 90% and a specificity
of 100% for the 37 test subjects [14]. Sinthanayothin et al.
proposed an automated screening system to detect blood
vessels in fundus images with a three-layer ANN that had
6 input neurons, 20 hidden neurons and 2 output neu-
rons. They achieved a sensitivity of 80.21% and a specifi-
city of 70.66% for 484 healthy retina images and 283
diabetic retinopathy images [15]. Gardner et al. developed
an ANN to differentiate diabetic retinopathy patients from
healthy subjects by extracting the blood vessels, exudates
and hemorrhages from images captured by a fundus cam-
era. They achieved a sensitivity of 88.4% and a specificity
of 83.5% for the detection of diabetic retinopathy when
147 diabetic and 32 healthy images were used to train the
backpropagation and 200 diabetic and 101 healthy images
were used for testing [16].
Most current research has used blood vessels and related
features extracted from fundus images to train different
types of ANNs to identify diseased eyes [17-19].
Taking into account the underlying relationship between
structural and optical measurements of the retinal tissue, it
is possible that test measurements from OCT images
based on the integration of structural and optical proper-
ties could provide more significant information and thus
superior diagnostic performance for classification methods
when used as input data. To the best of our knowledge,
only a few studies have used the thickness measurements
extracted from OCT images to train ANNs. For example,
the retinal nerve fiber layer thickness was extracted from
OCT images to train a relevance vector machine to predict
visual function in glaucoma [20]. In addition, the structural
and optical features of various intraretinal layers extracted
from OCT images have been used as discriminators to dif-
ferentiate diabetic eyes with and with no mild retinopathy
from healthy eyes [21]. In this study, we evaluate the cap-
ability of several structural and optical features of various
intraretinal layers extracted from OCT data to train an
ANN to discriminate between healthy eyes and diabetic
eyes with and with no mild retinopathy.
Results
A total of 930 OCT images obtained from 155 eligible
eyes of 99 participants were analyzed. The demographic
and clinical characteristics of the study population are
summarized in Table 1.
Table 1 Characteristics of the study population
Characteristic Controls DM MDR
Number of Participants 41 29 29
Number of Eyes 74 38 43
Age (years, mean ± SD) 34 ± 12 35 ± 10 43 ± 17
Female, N (% total eyes) 52 (70%) 20 (53%) 21 (49%)
Race (% Caucasian) 100 100 91
Hemoglobin A1c level (%) - 7.20 ± 0.90 8.51 ± 1.76
DM duration
(years, mean ± SD)
- 13 ± 5 22 ± 10
IOP (mmHg, mean ± SD) - 15.74 ± 1.77 15.09 ± 1.56
BCVA 1.00 ± 0.00 1.00 ± 0.00 0.97 ± 0.06
Total macular thickness 324.36 ± 10.27 316.72 ± 21.56 297.40 ± 21.79
Abbreviations: SD standard deviation, NA not applicable, DM diabetic eyes
without retinopathy, MDR diabetic eye with mild diabetic retinopathy.
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measured using sensitivity, specificity, and positive pre-
dictive values as figures of merit. Results for true positive
(TP), false negative (FN), true negative (TN), false posi-
tive (FP), positive predictive value (PPV), sensitivity and
specificity in Test 1 were calculated to evaluate the clas-
sifications (see Tables 2 and 3). In this classification test,
we explored the probability as to whether the subject’s
eye was healthy (diagnostic condition). Table 2 shows
the sensitivity, specificity, predictive values and positive
predictive values obtained when training the Bayesian
radial basis function network using the thickness (TH)
and fractal dimension (FD) as the input and target fea-
tures of the retinal layers, respectively. Our results indi-
cated that the TP test for the healthy eyes was in the
[48–51] range when 54 healthy eyes were mixed with
43 diabetic eyes with mild retinopathy (MDR) in this
test. Particularly, TP achieved high values (49, 50 and 51,
respectively) for OCT parameters of the GCL + IPL com-
plex, OS and RPE. As indicated by the positive predictive
values, a high probability was achieved for the GCL + IPL
complex and OPL parameters (91% and 89%, respectively)Table 2 Test classification performance results obtained in Te
TH vs. FD RNFL (eye/scans) GCL + IPL (eye/scans) INL (eye/scans) OP
TP 48/288 49/294 48/288
FN 6/36 5/30 6/36
TN 10/60 35/210 23/138
FP 33/198 8/48 20/120
PPV 0.59 0.86 * 0.71
Sensitivity 0.89 0.91* 0.89
Specificity 0.23 0.81* 0.53
*denotes the intraretinal layer for which the sensitivity, specificity and PPV are grea
Sensitivity, specificity, predictive values (TP, FN, TN, FP) and positive predictive valu
using the thickness (TH) and fractal dimension (FD) as the input and target featuresindicating that the subject really has a healthy eye. The TN
test was in the [9–36] range and high TN values (35 and
36, respectively) were achieved for the GCL + IPL complex
and OPL features used in this particular tests. More-
over, high values for sensitivity, specificity and PPV
(≥0.80) were only obtained for the GCL + IPL complex
and OPL parameters.
Table 3 shows the sensitivity, specificity, predictive
values and positive predictive values obtained when
training the Bayesian radial basis function network using
the total reflectance and fractal dimension as the input
and target features, respectively. Our results indicated
that the TP and TN tests for healthy eyes were in the
[48–51] and [9–36] ranges; respectively. As indicated by
the positive predictive values, a high probability was
achieved for the features of the GCL + IPL complex and
OPL (91% and 89%, respectively) indicating that the sub-
ject really has a healthy eye. Specifically, high TN values
(35 and 36, respectively) were achieved for the parame-
ters of the GCL + IPL complex and OPL. Moreover, high
values for sensitivity, specificity and PPV (≥0.80) were
only obtained for the features of the GCL + IPL complex
and OPL. Therefore, there is high probability (≥80%) the
subject will have a healthy GCL + IPL complex and OPL
structure.
Tables 4 and 5 show results obtained after using differ-
ent sizes of training data sets (20, 30 and 40 healthy
eyes, respectively) in Test 2. When training the Bayesian
radial basis function network using the thickness (total
reflectance) and fractal dimension as the input and tar-
get features, our results demonstrated that the FN and
FP values remaining at a given sensitivity of ≥ 80% for
the GCL + IPL complex’s parameters were stable despite
the amount of healthy eyes used in the training task,
whereas the values of FN remaining for the OPL were
slightly reduced with the increased number of healthy
eyes used to train the ANN. Additionally, the TN value
for the parameters of the GCL + IPL complex was stable.
Our results showed relatively high PPV, as well as high
sensitivity and specificity (≥0.80) in both the GCL + IPLst 1
L (eye/scans) ONL + IS (eye/scans) OS (eye/scans) RPE (eye/scans)
48/288 48/288 50/300 51/306
6/36 6/36 4/24 3/18
36/216 10/60 9/54 11/66
7/42 33/198 34/204 32/192
0.87 * 0.59 0.60 0.61
0.89* 0.89 0.93 0.94
0.84* 0.23 0.21 0.26
ter than 80%.
es (PPV) obtained when training the Bayesian radial basis function network
of the given retinal layers, respectively.
Table 3 Test classification performance results obtained in Test 1 after using the total reflectance as an input feature
TR vs. FD RNFL (eye/scans) GCL + IPL (eye/scans) INL (eye/scans) OPL (eye/scans) ONL + IS (eye/scans) OS (eye/scans) RPE (eye/scans)
TP 48/288 49/294 48/288 48/288 48/288 50/300 51/306
FN 6/36 5/30 6/36 6/36 6/36 4/24 3/18
TN 10/60 35/210 23/138 37/222 9/54 9/54 11/66
FP 33/198 8/48 20/120 6/36 34/204 34/204 32/192
PPV 0.59 0.86 0.71 0.89 0.59 0.60 0.61
Sensitivity 0.89 0.91* 0.89 0.89* 0.89 0.93 0.94
Specificity 0.23 0.81* 0.53 0.86* 0.21 0.21 0.26
*denotes the intraretinal layer for which the sensitivity, specificity and PPV are greater than 80%.
Sensitivity, specificity, predictive values (TP, FN, TN, FP) and positive predictive values (PPV) obtained when training the Bayesian radial basis function network
using the total reflectance (TR) and fractal dimension (FD) as the input and target features, respectively.
Somfai et al. BMC Bioinformatics 2014, 15:106 Page 4 of 10
http://www.biomedcentral.com/1471-2105/15/106complex and OPL’s parameters. Our results showed
that PPV had a slight decreasing trend for both the
GCL + IPL complex and OPL’s parameters when the
number of healthy subjects increased from 20 to 40 in
the training task, which was due to a decrease in test sub-
jects (healthy eyes).
Results obtained in Test 3 after training the Bayesian
radial basis function network with the thickness meas-
urement and fractal dimension as the input and target
features are shown in Table 6. In this classification test,
we explored the probability as to whether a diabetic eye
had MDR (diagnostic condition). Our results indicated
high TP values for features of the RNFL, GCL + IPL
complex, OS and RPE. Additionally, the sensitivity, spe-
cificity and positive predicted values were greater or
close to 0.70 in the RNFL, OS and RPE. Interestingly,
the GCL + IPL complex’s features didn’t show a PPV
greater than 80%.
In general, the overall results indicate that the classi-
fier is effective to about 90 per cent (PPV values in
Tables 3 and 4) in making the correct prediction of the un-
known class (healthy eyes) when differentiating healthy
from MDR eyes by using the features of the GCL + IPL
complex and OPL in the diagnostic test (Test 1). However,
the classifier was not effective (~44.5%) in making theTable 4 Model testing results obtained after changing the siz
Size of the training
data set
20 healthy eyes
TH vs. FD GCL + IPL (eye/scans) OPL (eye/scans) GCL + IPL (
TP 49/294 48/288 39/
FN 5/30 6/36 5/
TN 35/210 36/216 35/
FP 8/48 7/42 8/
PPV 0.86 0.87 0.8
Sensitivity 0.91 0.89 0.8
Specificity 0.81 0.84 0.8
Results of sensitivity, specificity, accuracy, predictive values and positive predictive
radial base function network with 20, 30 and 40 healthy eyes with the thickness (THcorrect prediction of the unknown class (MDR eyes) when
discriminating between DM and MDR eyes using the same
intraretinal layer’s features (i.e. GCL + IPL complex and
OPL in Test 3). Interestingly, the classifier was more effect-
ive (PPV~ 74%) in making the correct prediction of the
unknown class (MDR eyes) when differentiating DM and
MDR eyes by using the features of the RNFL, OS and RPE
in the diagnostic test (Test 3). Table 7 shows the percent-
age of correct classifications for the GCL + IPL complex
and OPL features in tests 1 and 3.
Discussion
In this study, we presented and evaluated a nonlinear
prediction method for early retinopathy detection on
OCT retinal images. The proposed system consisted of
three phases: preprocessing and image segmentation,
candidate MDR feature detection, and feature set formu-
lation and classification. We have used sensitivity, speci-
ficity, predictive values (TP, TN, FP, FN) and PPV
parameters to measure the classification performance of
the ANN ensemble and the diagnostic ability of the inte-
grated OCT parameters. Quantitative tools for measuring
thickness information of the retinal tissue using OCT de-
vices are in common clinical use, but to our knowledge
there have been no algorithms available to analyze thee of the training data set
30 healthy eyes 40 healthy eyes
eye/scans) OPL (eye/scans) GCL + IPL (eye/scans) OPL (eye/scans)
234 39/234 29/174 29/174
30 5/30 5/30 5/30
210 36/216 35/210 36/216
48 7/42 8/48 7/42
3 0.85 0.78 0.81
9 0.89 0.85 0.85
1 0.84 0.81 0.84
values obtained for the GCL + IPL complex and OPL when training the Bayesian
) and fractal dimension (FD) as the input and target features, respectively.
Table 5 Model testing results obtained after changing the size of the training data set and using the TR as an
input feature
Size of the training
data set
20 healthy eyes 30 healthy eyes 40 healthy eyes
TR vs. FD GCL + IPL (eye/scans) OPL (eye/scans) GCL + IPL (eye/scans) OPL (eye/scans) GCL + IPL (eye/scans) OPL (eye/scans)
TP 49/294 48/288 39/234 39/234 29/174 29/174
FN 5/30 6/36 5/30 5/30 5/30 5/30
TN 35/210 37/222 35/210 36/216 35/210 37/222
FP 8/48 6/36 8/48 7/42 8/48 6/36
PPV 0.86 0.89 0.83 0.85 0.78 0.83
Sensitivity 0.91 0.89 0.89 0.89 0.85 0.85
Specificity 0.81 0.86 0.81 0.84 0.81 0.86
Results of sensitivity, specificity, accuracy, predictive values and positive predictive values obtained for the GCL + IPL complex and OPL when training the Bayesian
radial basis function network with 20, 30 and 40 healthy eyes with the total reflectance (TR) and fractal dimension (FD) as the input and target features, respectively.
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combine them with structural information to assess
the integrity and better predict the lack of integrity of
the retinal layers in diabetic eyes. The use of the pre-
dictability of retinal layer integrity’s loss from struc-
tural and optical features by the Bayesian radial basis
function network played a key role in the neural loss
assessment in diabetic eyes. In our proposed method,
the stable trend of the FN values (of healthy testing eyes
in Test 2) validated the reliability of the methodology.
Our results demonstrate that the GCL + IPL complex
and OPL parameters could be predicted and used to dis-
criminate between MDR and healthy eyes by using either
the TH/FD or TR/FD pairs as the input/target features in
the Bayesian radial basis function network. The high sen-
sitivity and specificity values obtained when using struc-
tural and optical parameters of the GCL + IPL complex
and OPL suggest that the Bayesian radial basis function
network can be used to discriminate between MDR and
healthy eyes with the selected input and target features
extracted from OCT images. In particular, the fractal
dimension, which represents the roughness of the intrar-
etinal layer structure, could certainly be used to differen-
tiate MDR from healthy eyes. Our results suggest thatTable 6 Test classification performance results obtained in Te
TH vs. FD RNFL (eye/scans) GCL + IPL. (eye/scans) INL (eye/scans) O
TP 18/108 18/108 15/90
FN 5/30 5/30 8/48
TN 30/180 26/156 32/192
FP 8/48 12/72 6/36
PPV 0.69 0.60 0.71
Sensitivity 0.78 0.78 0.65
Specificity 0.79 0.68 0.84
*denotes the intraretinal layer for which the sensitivity, specificity and PPV are grea
Sensitivity, specificity, predictive values (TP, FN, TN, FP) and positive predictive valu
using the thickness (TH) and fractal dimension (FD) as the input and target featuresthe GCL + IPL complex and OPL are more susceptible to
early damage in MDR eyes. The low RNFL specificity and
PPV values indicated that RNFL parameters were not
good input/output targets for use in ANNs to differenti-
ate between MDR and healthy eyes. Interestingly, the fea-
tures of the RNFL, OS and RPE better predicted the lack
of integrity of the retinal structure when discriminating
between MDR and DM eyes. This particular result is in
agreement with previous studies reporting changes in
the outer retinal segment when comparing the macular
thickness in diabetic subjects with mild retinopathy and
healthy eyes [22,23]. The above finding may prove to be
useful for the better detection of mild diabetic retinopathy
by using optical coherence tomography imaging.
There were some limitations in this study. First, com-
parisons across studies were not possible, because no
studies have been conducted to investigate thickness and
optical properties of the retinal tissue together, using
ANNs. Second, larger sample sizes would provide more
accurate and robust estimations of the classification test
performance. However, our results can be used as the
basis for further improving the diagnostic accuracy of
early DR detection in the near future. Third, the specific
automated classification method that we chose is likelyst 3
PL (eye/scans) ONL + IS (eye/scans) OS (eye/scans) RPE (eye/scans)
4/24 10/60 18/108 20/120
19/114 13/78 5/30 3/18
28/168 26/162 31/186 33/198
10/60 12/72 7/42 5/30
0.29 0.45 0.72 0.80*
0.17 0.43 0.78 0.87*
0.74 0.68 0.82 0.87*
ter than 80%.
es (PPV) obtained when training the Bayesian radial basis function network
, respectively.
Table 7 Percentage of correct classifications as a function of eyes used in training and testing in tests 1 and 3
Intraretinal Layer Number of eyes used for training Number of eyes used for testing Percentage of correct classifications (%)
GC + IPL Test 1 20 Healthy 97 91
Test 3 20 MDR 61 42
OPL Test 1 20 Healthy 97 89
Test 3 20 MDR 61 47
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sons among other automated classification methods
should be made to obtain the best models for improving
the discriminant power of OCT integrated data for par-
ameter tests in decision support systems.
As already established, a Bayesian radial basis function
network can accommodate uncertainty in the dimension
of the model by adjusting the sizes to the complexity of
the data [24]. In this study, the TN, TP and the PPV
values remained stable despite the different sizes of
training data sets. However, training the Bayesian radial
basis function network may require more test subjects,
which would improve the precision of the differentiation
between healthy eyes and diabetic eyes with and without
mild retinopathy. Future studies should also evaluate the
methodology with data based on the new generation of
OCT devices that provide higher spatial resolution for
analyzing the retinal structure.
Conclusions
In this study, we have employed for the first time a
method that uses a Bayesian ANN with four pairs of in-
put and target features extracted from OCT data to dis-
criminate among MDR, healthy and DM eyes. The input
features used were the intraretinal layer thickness measure-
ment and total reflectance extracted from OCT images.
The fractal dimension of the GCL + IPL complex and OPL
predicted by the Bayesian radial basis function network
positively discriminated between MDR and healthy eyes.
Moreover, the thickness and fractal dimension parameters
of the RNFL, OS and RPE show promise for diagnostic
classification between MDR and DM eyes. The results
demonstrated that the proposed Bayesian radial basis func-
tion network’s classification can be used in a computer-
aided diagnostic system for discriminating between healthy
eyes and diabetic eyes with early retinopathy as it identified
and detected retinal features with high probability for the
proportion of patients with positive test results who were
correctly diagnosed. Our study showed that the combin-
ation of structural and optical information from OCT data
has the potential to improve parameter tests that bet-
ter reflect the diabetic retinal changes that occur during
the progression of the disease, providing more relevant in-
formation to DR diagnostic routines. Such improvements
could facilitate the practical implementation of ANNs as
decision support systems in DR diagnostics.Methods
A total of 120 participants (190 eyes) were recruited be-
tween October 2007 and December 2010 at the Depart-
ment of Ophthalmology, Semmelweis University, Budapest,
Hungary under a Juvenile Diabetes Research Foundation
study. The research adhered to the tenets set forth in the
declaration of Helsinki. Instutional Review Board approval
was obtained both at Semmelweis University and the
Miller School of Medicine, University of Miami. In this
prospective study, enrollment was offered to all Type 1
diabetic patients referred to the comprehensive ophthal-
mology clinic that had diabetic retinopathy up to ETDRS
level 35 without macular edema, as well as diabetic pa-
tients with no retinopathy [25,26]. Moreover, we did not
include patients with proliferative disease, clinically signifi-
cant macular edema (CSME) and with anatomic abnor-
malities that could distort macular architecture, such as
glaucoma, vitreoretinal traction and epiretinal membranes.
We enrolled only patients over the age of 18 and written
informed consent was obtained from each subject. OCT
examination was performed in healthy and diabetic eyes
with and with no retinopathy.
Once the subject was enrolled in the study, only one
visit was required to perform a comprehensive eye exam-
ination including intraocular pressure (using Goldmann
tonometer) and slit-lamp examination. Fundus images
were obtained and classified by an experienced grader ac-
cording to the criteria of the ETDRS protocol [23]. The
grader classified images without being aware of the OCT
findings and clinical data. In addition, a hemoglobin A1c
level test was required at this visit for diabetic patients
with no past glycemic control. No additional tests were
required after this primary visit and during the time the
study was completed. Inclusion criteria for healthy con-
trols included best-corrected visual acuity of 20/25 or
better, no history of any current ocular or systematic
disease, and a normal appearing macula on contact lens
biomicroscopy. Patients with any medical condition that
might affect visual function other than type 1 diabetes,
or treatments with medications that might affect retinal
thickness were excluded from the study. Moreover, pa-
tients who have recently undergone cataract surgery,
or with any history of intraocular surgery, and patients
with currently unstable blood sugars or who have re-
cently been placed on insulin pump therapy were also ex-
cluded from the study.
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of low quality OCT scans (1) and other diseases listed
under the exclusion criteria (amblyopic (3), chorioretinitis
(2), moderate DR (6), no DR (2), epiretinal membrane
(1), panretinal photocoagulation (5), pars plana vitrec-
tomy & panretinal photocoagulation (1), pigment epithelial
detachment & central serous chorioretinopathy (1), type 2
DM (8), optic nerve disease (3), and severe DR (2)). The
remaining 155 eligible eyes from 99 participants were
analyzed, which included a total of 74 healthy eyes
(34 ± 12 yrs, 52 female, 22 male), 38 eyes with type 1 dia-
betes mellitus (DM) with no retinopathy (35 ± 10 yrs,
20 female, 18 male) and 43 eyes with mild diabetic retinop-
athy (MDR, 43 ± 17 yrs, 21 female, 22 male) on biomicro-
scopy were included in the study (see Table 1).
The OCT system (Stratus OCT, Carl Zeiss Meditec,
Dublin, California) used in this study employs a broad-
band light source, delivering an output power of 1 mW
at the central wavelength of 820 nm with a bandwidth of
25 nm. The light source yields 12 μm axial resolution in
free space that determines the imaging axial resolution
of the system. A cross-sectional image is achieved by the
combination of axial reflectance while the sample is
scanned laterally. All Stratus OCT study cases were ob-
tained using the macular thickness map protocol. This
protocol consists of six radial scan lines centered on the
fovea, each having a 6 mm transverse length. In order to
obtain the best image quality, focusing and optimization
settings were controlled and scans were accepted only if
the signal strength was above 6 (preferably 9–10) [27].
Scans with foveal decentration (i.e. with center point
thickness SD > 10%) were repeated.
Macular radial line scans of the retina for each case
were exported to disc with the export feature available
in the Stratus OCT device and analyzed using a custom-
built software (OCTRIMA) [28]. A total of 6 cellular
layers of the retina were segmented on OCT images
based on their optical densities: the retinal nerve fiber
layer (RNFL), the ganglion cell and inner plexiform layer
complex (GCL + IPL), the inner nuclear layer (INL), the
outer plexiform layer (OPL), the outer nuclear layer and
inner photoreceptor segment (ONL + IS), outer photo-
receptor segment (OS) and retinal pigment epithelium
(RPE) (see Figure 1) [28]. As in some Fourier-domain
OCT (FD-OCT) systems, OCTRIMA facilitates the total
retinal thickness calculations between the ILM and the
inner boundary of the second hyperreflective band,
which has been attributed to the outer segment/retinal
pigment epithelium (OS/RPE) junction in agreement
with histological and previous OCT studies [29-32].
Structural and optical measurements, in addition to
thickness measurements, were extracted using features
measured locally for each intraretinal layer. The image
processing and diagnostic parameter calculations wereprogrammed in Matlab 7.0 (The Mathworks, Natick,
Massachusetts).
The macular region was divided into separate regions
(see Figure 1). The central disc is the foveola area with a
diameter of 0.35 mm. The remaining rings are the fovea,
parafoveal and perifoveal areas with a diameter of 1.85,
2.85 and 5.85 mm, respectively. Because an area with a
diameter of 1 mm is too large for the thickness of the
foveola region, which is only approximately 0.35 mm in
diameter, the custom-built map allows collection of more
precise information near the foveola region compared to
the ETDRS thickness map. In addition, no interpolation
is used in this method.
Structural and optical properties, in addition to thick-
ness measurements, were extracted from OCT-based
images and were used for the classification of healthy
eyes and diabetic eyes with and with no retinopathy
[21,33]. The structural and optical parameters that were
best able to discriminate between diabetic eyes and
healthy eyes, as revealed by statistical and receiver operat-
ing characteristic analyses from previous work [21,33],
were evaluated and validated by artificial neural networks
with a Bayesian radial basis function [24].
Our ANN classifier consisted of an ensemble of two
input neurons with a Bayesian radial basis function and
one output neuron. Therefore for each candidate intrar-
etinal layer we have two features (input parameters) that
are fed into the ANN to predict one output feature in
each classification test. The ANNs were implemented
in Matlab 7.0 (The Mathworks, Natick, Massachusetts)
using Markov chain Monte Carlo (MCMC) algorithms.
In order to cancel out interdata variations, a correlation
matrix based on standardized values of all parameters
was used in our study. Therefore, each dataset’s feature
was normalized to have zero mean and unit variance by
dividing the mean corrected data by the respective SD
before further processing. The relative error εγ between
the predicted and measured values was used to evaluate
the predicted values (see Eq.1).
εγ ¼ V γ−V
 
=V ð1Þ
where V denotes the measured values of the output pa-
rameters extracted from the unknown subjects and Vp
denotes the predicted values of the output parameters.
The distribution of the relative errors Ep was assumed to
be the Gaussian function (see Eq.2),
f xð Þ ¼ 1ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2πσ2
p c− x−μð Þ
2
2σ2
ð2Þ
where μ μ is the average value of εγ; σ is the deviation of
εγ. Then, a proper positive parameter cy was used to de-
fine the range [μ − cρσ, μ + cρσ]. By integrating the Gaussian
Figure 1 Custom-built method showing macular sectors. A) Fundus image of a healthy eye showing the Stratus OCT’s radial lines protocol.
B) Regions shown are: foveola (a) with a diameter of 0.35 mm, foveal region (b) with a diameter of 1.85 mm, parafoveal region (c) with a
diameter of 2.85 mm and perifoveal (d) region with a diameter of 5.85 mm.
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calculated as:
S cρ
  ¼
Z μþcρσ
μ−cρσ
f xð Þdx ¼
Z uþcρσ
μ−cρσ
1ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2πσ2
p c− x−μð Þ
2
2c2
dx
¼ crf cγ=
ﬃﬃﬃ
2
p 
ð3Þ
The value of the Gaussian error function (cy) reflects
the possibility ratio of the set of relative errors εγ in the
range [μ − cρσ, μ + cρσ]. A series of typical values of
[cρS(cγ)] is listed in Table 8. In this study, the parameter
cy was initialized as 1.65, which yielded 90% accuracy for
the classification. Once the parameter cy was obtained
from the training set used for training the Bayesian radial
basis function network, the discrimination task was per-
formed on all subjects by comparing the measured values
and the predicted values using the Bayesian radial basis
function network.
Different training and classification tasks for discrim-
inating between diabetic and healthy eyes were per-
formed. Particularly, structural and optical parameters ofTable 8 Typical values of cp and Gaussian error function
cv s(cp)
1.28 80%
1.44 85%
1.65 90%
1.96 95%
2.58 99%intraretinal layers were chosen as the input and output
features for the Bayesian radial basis function networks
that would discriminate among MDR, healthy and DM
eyes. As indicated in previous work [21], thickness meas-
urement (TH), fractal dimension (FD) and total reflect-
ance (TR) showed better discrimination power than other
parameters among MDR, healthy and DM eyes. Therefore,
these three optimum parameters were used as the input
and output values required in the training task of Bayesian
radial basis function networks. Then, trained Bayesian
radial basis function networks were used to classify the
mixed test subjects (excluding the training subjects). To
explore the probabilistic relationships between the dia-
betic retinal disease and target features (i.e., symptoms),
we first performed the training task using a subset of the
data and different pairs of input and output target features.
Then, classification tasks were performed to obtain the
optimum distribution over the set of allowed models.
Additionally, a classification test’s performance as a func-
tion of training set size was used to assess adequacy of the
training data set in the development of the ANN scheme.
Therefore, different sizes of the training set were explored
and the corresponding results were compared. Specifically,
we first explored the probabilistic relationships between
the diabetic retinal disease and target features. Particularly,
a total of 20 healthy eyes were randomly selected from
the healthy group (out of 74 healthy eyes) to train the
Bayesian radial basis function network (Test 1). Different
pairs of input and target features extracted from all
intraretinal layers were used to train the Bayesian radial
basis function network and to classify a total of 43 MDR
eyes using the remaining 54 healthy eyes (not used in
training) from the healthy group. In this test, we evaluated
Somfai et al. BMC Bioinformatics 2014, 15:106 Page 9 of 10
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etinal layer parameters that could be predicted and used to
discriminate between MDR and healthy eyes. Second, we
performed model testing of the previous experiment by ex-
ploring different sizes of the training data subset (Test 2).
In this second test, different sizes of the training data sub-
set (20, 30 and 40 healthy eyes) were chosen to train the
Bayesian radial basis function network and corresponding
results were compared. Then, we tried to discriminate be-
tween DM and MDR eyes (Test 3). As in the previous test,
20 MDR eyes were randomly selected from the total 43
MDR eyes to train the Bayesian radial basis function net-
work with the TH/FD and TR/FD as the input and target
features, respectively. Then, the trained Bayesian radial
basis function network was used to classify the remaining
23 MDR eyes and 38 DM eyes.
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